Drug Information

Drug General Information
Drug ID
D00PCE
Former ID
DNC012741
Drug Name
BRL-24682
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526544]
Structure
Download
2D MOL

3D MOL
Formula
C16H22ClN3O2
Canonical SMILES
CN1C2CCC1CC(C2)NC(=O)C3=CC(=C(C=C3OC)N)Cl
InChI
1S/C16H22ClN3O2/c1-20-10-3-4-11(20)6-9(5-10)19-16(21)12-7-13(17)14(18)8-15(12)22-2/h7-11H,3-6,18H2,1-2H3,(H,19,21)
InChIKey
HTMNINCXKXABOI-UHFFFAOYSA-N
PubChem Compound ID
9797313
Target and Pathway
Target(s) 5-hydroxytryptamine receptor 3A Target Info Inhibitor [526544]
5-hydroxy-tryptamine 3B receptor Target Info Inhibitor [526544]
KEGG Pathway Serotonergic synapsehsa04726:Serotonergic synapse
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway 5HT3 type receptor mediated signaling pathwayP04375:5HT3 type receptor mediated signaling pathway
Reactome Ligand-gated ion channel transportR-HSA-975298:Ligand-gated ion channel transport
WikiPathways SIDS Susceptibility Pathways
Iron uptake and transportWP2670:Iron uptake and transport
References
Ref 526544J Med Chem. 2003 Feb 27;46(5):702-15.Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Ref 526544J Med Chem. 2003 Feb 27;46(5):702-15.Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.